Edition:
United Kingdom

Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

12.43USD
16 Jan 2019
Change (% chg)

$-0.51 (-3.94%)
Prev Close
$12.94
Open
$13.00
Day's High
$13.19
Day's Low
$12.42
Volume
221,862
Avg. Vol
281,346
52-wk High
$24.45
52-wk Low
$12.42

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.28 December 16 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 3 4 5
(3) HOLD 7 8 7 6
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.45 2.46 2.38 2.31

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 6 473.95 524.00 431.90 --
Quarter Ending Jun-19 6 513.29 583.20 471.60 --
Year Ending Dec-19 12 2,050.19 2,313.50 1,898.20 881.66
Earnings (per share)
Quarter Ending Mar-19 6 0.28 0.36 0.21 --
Quarter Ending Jun-19 6 0.32 0.41 0.27 --
Year Ending Dec-19 12 1.32 1.62 1.12 1.31
LT Growth Rate (%) 1 19.00 19.00 19.00 12.23

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 486.05 476.49 9.56 1.97
Quarter Ending Jun-18 462.85 462.33 0.52 0.11
Quarter Ending Mar-18 181.56 417.54 235.98 129.97
Quarter Ending Dec-17 197.70 182.91 14.79 7.48
Quarter Ending Sep-17 208.35 206.39 1.96 0.94
Earnings (per share)
Quarter Ending Sep-18 0.27 0.28 0.01 1.97
Quarter Ending Jun-18 0.23 0.24 0.01 5.49
Quarter Ending Mar-18 0.16 0.14 0.02 12.99
Quarter Ending Dec-17 0.12 0.11 0.01 4.93
Quarter Ending Sep-17 0.20 0.23 0.03 16.69

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 473.95 473.95 476.14 476.14 --
Quarter Ending Jun-19 513.29 513.29 514.55 514.55 --
Year Ending Dec-19 2,050.19 2,057.11 2,071.44 2,076.90 881.66
Earnings (per share)
Quarter Ending Mar-19 0.28 0.29 0.29 0.29 --
Quarter Ending Jun-19 0.32 0.33 0.33 0.33 --
Year Ending Dec-19 1.32 1.33 1.35 1.36 1.31

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 0 2
Earnings
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 0 2